Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) Equity Average (2016 - 2025)

Pediatrix Medical (MD) has disclosed Equity Average for 16 consecutive years, with $862.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Equity Average rose 19.84% to $862.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $862.2 million, a 19.84% increase, with the full-year FY2024 number at $807.0 million, down 7.28% from a year prior.
  • Equity Average was $862.2 million for Q3 2025 at Pediatrix Medical, up from $811.5 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $955.2 million in Q3 2023 to a low of $719.5 million in Q3 2024.
  • A 5-year average of $840.1 million and a median of $852.6 million in 2024 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: tumbled 49.28% in 2021, then rose 19.84% in 2025.
  • Pediatrix Medical's Equity Average stood at $871.2 million in 2021, then increased by 0.46% to $875.1 million in 2022, then rose by 3.81% to $908.5 million in 2023, then fell by 17.59% to $748.7 million in 2024, then increased by 15.16% to $862.2 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Equity Average are $862.2 million (Q3 2025), $811.5 million (Q2 2025), and $777.1 million (Q1 2025).